398 related articles for article (PubMed ID: 17243067)
1. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.
Puthanakit T; Aurpibul L; Oberdorfer P; Akarathum N; Kanjananit S; Wannarit P; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2007 Feb; 44(4):599-604. PubMed ID: 17243067
[TBL] [Abstract][Full Text] [Related]
2. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
[TBL] [Abstract][Full Text] [Related]
3. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
4. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents.
Eley B; Nuttall J; Davies MA; Smith L; Cowburn C; Buys H; Hussey G
S Afr Med J; 2004 Aug; 94(8):643-6. PubMed ID: 15352588
[TBL] [Abstract][Full Text] [Related]
5. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
6. Treating children with HIV infection: what we can do, we should do.
Oleske JM
Clin Infect Dis; 2007 Feb; 44(4):605-6. PubMed ID: 17243068
[No Abstract] [Full Text] [Related]
7. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program.
Puthanakit T; Oberdorfer A; Akarathum N; Kanjanavanit S; Wannarit P; Sirisanthana T; Sirisanthana V
Clin Infect Dis; 2005 Jul; 41(1):100-7. PubMed ID: 15937769
[TBL] [Abstract][Full Text] [Related]
8. Low effectiveness of highly active antiretroviral therapy and high mortality in the Greenland HIV-infected population.
Lohse N; Ladefoged K; Pedersen L; Jensen-Fangel S; Sørensen HT; Obel N
Scand J Infect Dis; 2004; 36(10):738-42. PubMed ID: 15513400
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
[TBL] [Abstract][Full Text] [Related]
10. Predictors of mortality among HIV-infected children receiving highly active antiretroviral therapy.
Njom Nlend AE; Loussikila AB
Med Mal Infect; 2017 Feb; 47(1):32-37. PubMed ID: 27609595
[TBL] [Abstract][Full Text] [Related]
11. Predicting mortality in HIV-infected children initiating highly active antiretroviral therapy in a resource-deprived setting.
Nugent J; Edmonds A; Lusiama J; Thompson D; Behets F;
Pediatr Infect Dis J; 2014 Nov; 33(11):1148-55. PubMed ID: 24945879
[TBL] [Abstract][Full Text] [Related]
12. Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients.
Nuesch R; Geigy N; Schaedler E; Battegay M
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):684-7. PubMed ID: 12373504
[TBL] [Abstract][Full Text] [Related]
13. Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents.
Bunupuradah T; Sricharoenchai S; Hansudewechakul R; Klinbuayaem V; Teeraananchai S; Wittawatmongkol O; Akarathum N; Prasithsirikul W; Ananworanich J;
Pediatr Infect Dis J; 2015 Mar; 34(3):e58-62. PubMed ID: 25478649
[TBL] [Abstract][Full Text] [Related]
14. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy.
Kline MW; Rugina S; Ilie M; Matusa RF; Schweitzer AM; Calles NR; Schwarzwald HL
Pediatrics; 2007 May; 119(5):e1116-20. PubMed ID: 17420261
[TBL] [Abstract][Full Text] [Related]
16. The first 5 years of the family clinic for HIV at Tygerberg Hospital: family demographics, survival of children and early impact of antiretroviral therapy.
van Kooten Niekerk NK; Knies MM; Howard J; Rabie H; Zeier M; van Rensburg A; Frans N; Schaaf HS; Fatti G; Little F; Cotton MF
J Trop Pediatr; 2006 Feb; 52(1):3-11. PubMed ID: 15947012
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects.
Saez-Llorens X; Violari A; Ndiweni D; Yogev R; Cashat M; Wiznia A; Chittick G; Harris J; Hinkle J; Blum MR; Adda N; Rousseau F;
Pediatrics; 2008 Apr; 121(4):e827-35. PubMed ID: 18332076
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children.
Lapphra K; Vanprapar N; Chearskul S; Phongsamart W; Chearskul P; Prasitsuebsai W; Chokephaibulkit K
Int J Infect Dis; 2008 Nov; 12(6):e33-8. PubMed ID: 18573672
[TBL] [Abstract][Full Text] [Related]
19. Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India.
Banerjee T; Pensi T; Banerjee D; Grover G
Ann Trop Paediatr; 2010; 30(1):27-37. PubMed ID: 20196931
[TBL] [Abstract][Full Text] [Related]
20. Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia.
Ebissa G; Deyessa N; Biadgilign S
AIDS Care; 2015; 27(6):723-30. PubMed ID: 25599414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]